An Overview of the Deubiquitinase USP53: A Promising Diagnostic Marker and Therapeutic _target
- PMID: 39300775
- PMCID: PMC11348463
- DOI: 10.2174/0113892037292440240518194922
An Overview of the Deubiquitinase USP53: A Promising Diagnostic Marker and Therapeutic _target
Abstract
Ubiquitination and deubiquitination are important mechanisms to maintain normal physiological activities, and their disorders or imbalances can lead to various diseases. As a subgroup of deubiquitinases (DUBs), the ubiquitin-specific peptidase (USP) family is closely related to many biological processes. USP53, one of the family members, is widely expressed in human tissues and participates in a variety of life activities, such as cell apoptosis, nerve transmission, and bone remodeling. Mutations in the USP53 gene can cause cholestasis and deafness and may also be a potential cause of schizophrenia. Knockout of USP53 can alleviate neuropathic pain induced by chronic constriction injury. Loss of USP53 up-regulates RANKL expression, promotes the cytogenesis and functional activity of osteoclasts, and triggers osteodestructive diseases. USP53 plays a tumor-suppressive role in lung cancer, renal clear cell carcinoma, colorectal cancer, liver cancer, and esophageal cancer but reduces the radiosensitivity of cervical cancer and esophageal cancer to induce radioresistance. Through the in-depth combination of literature and bioinformatics, this review suggested that USP53 may be a good potential biomarker or therapeutic _target for diseases.
Keywords: USP53; bioinformatics.; deubiquitinase; diagnostic marker; therapeutic _target; ubiquitination.
Conflict of interest statement
The author(s) declare no conflict of interest, financial or otherwise.
Figures
Similar articles
-
USP53 promotes apoptosis and inhibits glycolysis in lung adenocarcinoma through FKBP51-AKT1 signaling.Mol Carcinog. 2020 Aug;59(8):1000-1011. doi: 10.1002/mc.23230. Epub 2020 Jun 8. Mol Carcinog. 2020. PMID: 32511815
-
Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.Cancer Med. 2021 Jun;10(11):3674-3688. doi: 10.1002/cam4.3911. Epub 2021 May 11. Cancer Med. 2021. PMID: 33973730 Free PMC article.
-
USP53 activated by H3K27 acetylation regulates cell viability, apoptosis and metabolism in esophageal carcinoma via the AMPK signaling pathway.Carcinogenesis. 2022 May 19;43(4):349-359. doi: 10.1093/carcin/bgab123. Carcinogenesis. 2022. PMID: 34919659
-
Biallelic Mutations in Ubiquitin-Specific Peptidase 53 (USP53) Causing Progressive Intrahepatic Cholestasis. Report of a Case With Review of Literature.Pediatr Dev Pathol. 2022 Mar-Apr;25(2):207-212. doi: 10.1177/10935266211051175. Epub 2021 Nov 22. Pediatr Dev Pathol. 2022. PMID: 34809518 Review.
-
Ubiquitin-specific peptidase 1: assessing its role in cancer therapy.Clin Exp Med. 2023 Nov;23(7):2953-2966. doi: 10.1007/s10238-023-01075-4. Epub 2023 Apr 24. Clin Exp Med. 2023. PMID: 37093451 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials